Geron

Companies involved in researching medical techniques using stem cells saw shares tumble across the board Tuesday, a day after a federal court ruled to block government funding for stem cell research.

The Food and Drug Administration cleared the way on Friday for California biotech firm Geron to begin human clinical trials of its experimental embryonic stem cell-based therapy to heal spinal cord injuries in paraplegic patients. Geron claims this is the first such trial in humans.

Pharmaceutical company Geron announced that the U.S. Food and Drug Administration has lifted the clinical hold it had placed on the company's new drug application, allowing it to proceed with a clinical trial of GRNOPC1 in patients suffering from acute spinal cord injury.

Long an old-line drug company, Pfizer is looking increasingly like a new biotech these days, especially after licensing a stem cell therapy. Athersys' MultiStem is a therapy that consists of a special class of stem cells obtained from the bone marrow of healthy, adult donors to treat inflammatory bowel disease.

The Nobel Prize for Medicine was won by three American scientists Monday. The trio won the coveted award for answering some of the most basic questions in life, further deciphering one of our building blocks -- the human cell. The three Americans joining the long list of Nobel Laureates in their...

It's not easy being first. Biotech company Geron (GERN) had to wait more than a year before getting the green light from federal regulators in January to begin the first study using human embryonic stem cell-based therapies in humans. The early-stage trial is looking at the safety of its drug...

Geron Corp (GERN) shares, which dropped as much as 15 percent earlier today, declined over 10 percent by midday trading after regulators delayed clinical trials on its spinal cord injury treatment. The stem cell research company today announced that the FDA has placed a clinical hold on its...

On Monday, President Barack Obama signed an order lifting restrictions on federal funding of human embryonic stem cell research. Despite many beliefs to the contrary, no ban on stem cell research exists; only a ban on its public funding. In 1996 Congress banned public funding on the creation of new...